AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Decker Stern Sadie sells 1466 Dexcom shares at $88.99 on July 28
ByAinvest
Tuesday, Jul 29, 2025 4:23 pm ET1min read
On July 28, 2025, DexCom Inc. (DXCM) announced that EVP, Chief HR Officer Sadie Stern sold 1,466 shares at a price of $88.99 per share.
On July 28, 2025, DexCom Inc. (DXCM) reported that EVP and Chief HR Officer Sadie Stern sold 1,466 shares of the company's stock at a price of $88.99 per share. The transaction was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission (SEC) [1].The sale occurred pursuant to a 10b5-1 trading plan, which allows for the orderly disposition of shares owned by Ms. Stern. This plan is designed to facilitate the sale of shares without influencing the market price. The filing indicates that the sale was part of a broader strategy to manage Ms. Stern's holdings in the company [1].
According to the filing, the sale of 1,466 shares reduced Ms. Stern's beneficial ownership in DexCom to 106,689 shares. This represents a 10% decrease in her ownership stake, as she previously owned 118,155 shares [1].
The sale comes amidst a period of significant institutional activity in DexCom's stock. In the first quarter of 2025, Allianz Asset Management GmbH reduced its stake by 22.9%, while other institutional investors, such as Golden State Wealth Management LLC and Private Trust Co. NA, increased their holdings [2].
The recent insider selling activity at DexCom follows a trend of institutional investors adjusting their positions in the company. Over the last ninety days, insiders sold 27,190 shares of company stock valued at $2,281,732. Insiders now own 0.32% of the company's stock [2].
DexCom's stock performance has been mixed over the past year. The stock opened at $89.53 on Tuesday, July 2, 2025, and has a market cap of $35.11 billion. The company reported earnings per share of $0.32 for the most recent quarter, missing the consensus estimate of $0.33. However, the company's revenue for the quarter was up 12.5% year-over-year [2].
Analysts have provided a range of ratings and target prices for DexCom's stock. Four analysts have given a "hold" rating, fifteen have assigned a "buy" rating, and two have rated the stock as a "strong buy." The average rating is "Moderate Buy" with an average price target of $98.72 [2].
References:
[1] https://www.stocktitan.net/sec-filings/DXCM/form-4-dex-com-inc-insider-trading-activity-7870a73a6a13.html
[2] https://www.marketbeat.com/instant-alerts/filing-dexcom-inc-nasdaqdxcm-holdings-decreased-by-allianz-asset-management-gmbh-2025-07-29/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet